163 related articles for article (PubMed ID: 34147661)
1. Elevated preoperative CA125 levels predicts poor prognosis of hilar cholangiocarcinoma receiving radical surgery.
Xu ZL; Ou YJ; Dai HS; Wan K; Bie P; Chen ZY; Zhang LD; Zhang CC
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101695. PubMed ID: 34147661
[TBL] [Abstract][Full Text] [Related]
2. [The effect of prealbumin on the long-term prognosis of hilar cholangiocarcinoma following radical surgery].
Chen ZY; Liu ZP; Dai HS; Jiang Y; He Y
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):378-386. PubMed ID: 35272430
[No Abstract] [Full Text] [Related]
3. Preoperative serum CA125 level is a good prognostic predictor in patients with intrahepatic cholangiocarcinoma after hepatectomy: A single-center retrospective study.
Meng J; Weng J; Wu J; Mao H; Huang P; Chen S; Liu L
Medicine (Baltimore); 2023 Sep; 102(36):e34839. PubMed ID: 37682202
[TBL] [Abstract][Full Text] [Related]
4. Postoperative morbidity adversely impacts oncological prognosis after curative resection for hilar cholangiocarcinoma.
Liu ZP; Chen WY; Zhang YQ; Jiang Y; Bai J; Pan Y; Zhong SY; Zhong YP; Chen ZY; Dai HS
World J Gastroenterol; 2022 Mar; 28(9):948-960. PubMed ID: 35317056
[TBL] [Abstract][Full Text] [Related]
5. Relationship between serum MMP-9 level and prognosis after radical resection for Hilar cholangiocarcinoma patients.
Li O; Yi W; Yang P; Guo C; Peng C
Acta Cir Bras; 2019 Apr; 34(4):e201900409. PubMed ID: 31038586
[TBL] [Abstract][Full Text] [Related]
6. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.
Zhang XF; Beal EW; Chakedis J; Chen Q; Lv Y; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
World J Surg; 2018 Sep; 42(9):2919-2929. PubMed ID: 29404753
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis of laparoscopic surgery and open surgery for hilar cholangiocarcinoma: a retrospective cohort study.
Yin Y; Tao J; Xian Y; Hu J; Li Y; Li Q; Xiong Y; He Y; He K; Li J
World J Surg Oncol; 2024 Feb; 22(1):58. PubMed ID: 38369496
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China.
Hu HJ; Jin YW; Shrestha A; Ma WJ; Wang JK; Liu F; Zhu YY; Zhou RX; Regmi P; Cheng NS; Li FY
Cancer Med; 2019 Apr; 8(4):1567-1575. PubMed ID: 30868740
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.
Li B; Xiong XZ; Zhou Y; Wu SJ; You Z; Lu J; Cheng NS
World J Gastroenterol; 2017 Sep; 23(36):6685-6693. PubMed ID: 29085213
[TBL] [Abstract][Full Text] [Related]
10. Vascular invasion and lymph node metastasis mediate the effect of CA242 on prognosis in hilar cholangiocarcinoma patients after radical resection.
Heng G; Huang B; Shen Y; Wang D; Lan Z; Yao Y; Zhang J; Jia J; Zhang C
Front Oncol; 2022; 12():1071439. PubMed ID: 36578939
[TBL] [Abstract][Full Text] [Related]
11. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
Yang XQ; Chen C; Wang FB; Peng CW; Li Y
Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
[TBL] [Abstract][Full Text] [Related]
12. Prediction of prognosis and resectability using MR imaging, clinical, and histopathological findings in patients with perihilar cholangiocarcinoma.
Yoo J; Kim JH; Bae JS; Kang HJ
Abdom Radiol (NY); 2021 Sep; 46(9):4159-4169. PubMed ID: 33929600
[TBL] [Abstract][Full Text] [Related]
13. The preoperative elevated plasma fibrinogen level is associated with the prognosis of hilar cholangiocarcinoma.
Ye XW; Hu HJ; Xiong XZ; Lu J; Cheng NS
Surg Today; 2021 Aug; 51(8):1352-1360. PubMed ID: 33651221
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of age-adjusted Charlson comorbidity index in laparoscopic resection for hilar cholangiocarcinoma.
Cai C; Tao L; Li D; Wang L; Xiao E; Luo G; Yan Z; Wang Y; Li D
Scand J Gastroenterol; 2024 Mar; 59(3):333-343. PubMed ID: 38018772
[TBL] [Abstract][Full Text] [Related]
16. Should more aggressive surgical resection be considered in the treatment for Bismuth types I and II hilar cholangiocarcinoma? A meta-analysis.
Hu YF; Hu HJ; Lv TR; He ZQ; Dai YS; Li FY
Asian J Surg; 2023 Oct; 46(10):4115-4123. PubMed ID: 36586821
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer.
Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y
Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053
[TBL] [Abstract][Full Text] [Related]
18. Intrahepatic cholangiocarcinoma: Introducing the preoperative prediction score based on preoperative imaging.
Bartsch F; Hahn F; Müller L; Baumgart J; Hoppe-Lotichius M; Kloeckner R; Lang H
Hepatobiliary Pancreat Dis Int; 2021 Jun; 20(3):262-270. PubMed ID: 32861577
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
20. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY
Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
